TUMORS OF THE TESTICULAR ADNEXA and SPERMATIC CORD



Similar documents
Case presentation: Mesothelioma of the tunica vaginalis. Dr Ben Shepherd Pathology Queensland Princess Alexandra Hospital Brisbane

Update on Mesothelioma

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY

PATHOLOGY OF THE PLEURA: Mesothelioma and mimickers Necessity of Immunohistochemistry. M. Praet

Today s Topics. Tumors of the Peritoneum in Women

Outline. Workup for metastatic breast cancer. Metastatic breast cancer

Case of the. Month October, 2012

The develpemental origin of mesothelium

Changes in Breast Cancer Reports After Second Opinion. Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain

Immunohistochemistry on cytology specimens from pleural and peritoneal fluid

Protocol for the Examination of Specimens From Patients With Tumors of the Peritoneum

PRIMARY SEROUS CARCINOMA OF PERITONEUM: A CASE REPORT

Effusions: Mesothelioma and Metastatic Cancers

The evolving pathology of solitary fibrous tumours. Luciane Dreher Irion MREH / CMFT / NSOPS

Diagnosis of Mesothelioma Pitfalls and Practical Information

Diagnostic Challenge. Department of Pathology,

Ovarian tumors Ancillary methods

Something Old, Something New.

Notice of Faculty Disclosure

Protocol applies to all primary borderline and malignant epithelial tumors, and malignant mesothelial neoplasms of the peritoneum.

Diseases. Inflammations Non-inflammatory pleural effusions Pneumothorax Tumours

3-F. Pathology of Mesothelioma

Introduction: Tumor Swelling / new growth / mass. Two types of growth disorders: Non-Neoplastic. Secondary / adaptation due to other cause.

Cytology : first alert of mesothelioma? Professor B. Weynand, UCL Yvoir, Belgium

Pathology of the Female Peritoneum, Common and Uncommon Problems

Académie internationale de Pathologie - Division arabe XX ème congrès novembre 2008 Alger. Immunohistochemistry in malignant mesotheliomas

SEMESTER VI 3 RD YEAR PATHOLOGY KIDNEY TUMORS

Practical Effusion Cytology

INFLAMMATORY PLEURAL EFFUSION

Ovarian mucinous lesions. Ovarian mucinous lesions: Common diagnostic dilemmas. Ovarian mucinous lesions: problematic issues

A. Pericardial smear. Examination of the pericardial aspirate can provide useful diagnostic information.

Case Report Mesothelioma of the tunica vaginalis testis with prominent adenomatoid features: a case report

How To Diagnose And Treat A Tumour In An Effusion

Case presentation. Awatif Al-Nafussi

Seattle. Case Presentations. Case year old female with a history of breast cancer 12 years ago. Now presents with a pleural effusion.

MAJOR PARADIGM SHIFT IN EARLY 1990S IN UNDERSTANDING RENAL CANCER

Frozen Section Diagnosis

Renal Tumors with Eosinophilic Cytoplasm: 2013 Classification. Jesse K. McKenney, MD Associate Head, Surgical Pathology

DESMOPLASTIC SMALL ROUND CELL TUMOR: A RARE PATHOLOGY PUZZLE

Carcinosarcoma of the Ovary

Neoplasms of the LUNG and PLEURA

Male. Female. Death rates from lung cancer in USA

Immunohistochemical differentiation of metastatic tumours

J of Evidence Based Med & Hlthcare, pissn , eissn / Vol. 2/Issue 33/Aug. 17, 2015 Page 5063

More than 2,500 people are diagnosed with mesothelioma in the UK each year.

The Diagnosis of Cancer in the Pathology Laboratory

Disclosures. Learning Objectives. Effusion = Confusion. Diagnosis Of Serous Cavity Effusions - Beware The Mesothelial Cell!

Pathology of lung cancer

R-16: Chronic nonspecific cervisit

MALIGNANT MESOTHELIOMA: A TYPICAL PRESENTATION IN AN ATYPICAL PATIENT

Epithelial Tumors of the Kidney Diagnostic Problems and Recently Described Entities

Cytopathology Case Presentation #8

General Rules SEER Summary Stage Objectives. What is Staging? 5/8/2014

CASE OF THE MONTH AUGUST-2015 DR. GURUDUTT GUPTA HEAD HISTOPATHOLOGY

PROTOCOL OF THE RITA DATA QUALITY STUDY

HKCPath Anatomical Pathology Peer Review and Scores : PDF version for download

Immunohistochemistry of soft tissue tumors

POSTMENOPAUSAL ASSESS AND WHAT TO DO

How To Test For Cancer

Primary -Benign - Malignant Secondary

Histopathology of Major Salivary Gland Neoplasms

Primary malignant gonadal mesotheliomas and asbestos

Case Report Predominantly Fibrous Malignant Mesothelioma in a Cat

Malignant mesothelioma of the pleura: relation

Malignant Peritoneal Mesothelioma in Women A Study of 75 Cases With Emphasis on Their Morphologic Spectrum and Differential Diagnosis

METASTATIC CLEAR CELL RENAL CELL CARCINOMA TO THE SUBCUTANEOUS AREA IN ILLIAC FOSSA AND ADRENAL GLAND WITHOUT AN IDENTIFIABLE PRIMARY TUMOR

Cystic Neoplasms of the Pancreas: A multidisciplinary approach to the prevention and early detection of invasive pancreatic cancer.

Renal Cell Carcinoma: Advances in Diagnosis B. Iványi, MD

Case Report Malignant Mesothelioma Mimicking Invasive Mammary Carcinoma in a Male Breast

YOUR LUNG CANCER PATHOLOGY REPORT

Plueral Malignancy: Radiologic-pathologic

The menstrual cycle Hypophysis

Histologic Subtypes of Renal Cell Carcinoma

- Slide Seminar - Endocrine pathology in non-endocrine organs. Case 11. Stefano La Rosa, Gioacchino D Ambrosio, Fausto Sessa

CHAPTER 2. Neoplasms (C00-D49) March MVP Health Care, Inc.

Testicular Mesothelioma

Emerging Subtypes in Renal Cancer. Donna E. Hansel, MD PhD Professor of Pathology, UC San Diego Division Chief, Anatomic Pathology

Video Microscopy Tutorial 5

Diagnostic Pitfalls In Thoracic Tumors

FRCPath Part 2 Histopathology Short Cases, autumn 2014

This module consists of four units which will provide the user a basic knowledge of cancer as a disease.

BIOBANK LPCE-NICE CHEST

Objectives. Mylene T. Truong, MD. Malignant Pleural Mesothelioma Background

BIOBANK LPCE-NICE CHEST

ASBESTOS EXPOSURE AND SARCOMATOID MALIGNANT PLEURAL MESOTHELIOMA Gorantla Sambasivarao 1, Namballa Usharani 2, Tupakula Suresh Babu 3

OBJECTIVES By the end of this segment, the community participant will be able to:

CT and MRI features of the Pathologic Subtypes of Papillary Renal Cell Carcinoma. Melissa Price, MD Aoife Kilcoyne, MD Mukesh G.

NEOPLASMS C00 D49. Presented by Jan Halloran CCS

Index. F Factor VIII-related antigen, see VWF FactorXIIIa, for dermatofibroma, HT, see Serotonin

Translocation Renal Cell Carcinomas

ATLAS OF HEAD AND NECK PATHOLOGY THYROID PAPILLARY CARCINOMA

Report series: General cancer information

THE PATHOLOGY OF MEDIASTINAL MASSES. Anatomic Distribution of Mediastinal Masses

Mesothelioma: Questions and Answers

Abstracts and References

BAP1 germline mutations A new Cutaneous Nevus Melanoma Syndrome. Thomas Wiesner

MODERN IMMUNOHISTOCHEMISTRY

Benign Liver Tumors. Cameron Schlegel PGY-1 3/6/2013

Rare Thoracic Tumours

Transcription:

TUMORS OF THE TESTICULAR ADNEXA and SPERMATIC CORD Victor E. Reuter, MD Memorial Sloan-Kettering Cancer Center reuterv@mskcc.org 66 th Annual Pathology Seminar California Society of Pathologists Short Course in Genitourinary Pathology MSKCC Disclosures: none

TESTICULAR APPENDAGES and CORD LESIONS Outline: Rete testis Tubuli efferentes/epididymis Mesothelium Soft tissue Metastatic disease

When confronted with an adnexal testicular mass, what should I be thinking about? Neoplastic or not? Reactive process, infection, infarct If neoplastic, primary or not? If primary, what type? Are there ancillary studies I can depend on? After I type it, what factors must I evaluate to predict progression and how do I stage the tumor? If metastatic, what are the more likely sources? Clinical history

METASTATIC DISEASE TO THE TESTIS Rarely is it the initial presentation of disease Epithelial tumors predominate Prostate Colon Kidney Melanoma Lymphoma Sarcoma

RETE TESTIS Benign Lesions Classification Hyperplasia Adenomatous hyperplasia Adenoma - Sertoliform adenoma Morphologic criteria Circumscribed Cystic or solid Cytologically banal For adenoma; not associated with other neoplasm

Normal anatomy

Pagetoid spread of ITGCN with reactive papillary hyperplasia of the rete

Reactive changes in the rete testis

Hilum Well circumscribed Banal appearing Inhibin /+ Sertoliform adenoma of the rete

PAX8

RETE TESTIS Adenocarcinoma Lesion centered in the hilum* Transition from normal to neoplastic epithelium* Absence of primary elsewhere Morphology incompatible with any other intrascrotal primary Proper immunohistochemical panel excluding other primaries *may be difficult to assess

RETE TESTIS Adenocarcinoma Clinical scenario: Adult males Unilateral painful testicular swelling With or without hydrocele Poor survival Pathology: Solid or cystic Mostly tubulopapillary (solid/spindled/reteform) Cuboidal to columnar cells Eosinophilic to basophilic cytoplasm

CK7 CEA CD15 PAX8

CYSTADENOMA OF THE EPIDIDYMIS vhl syndrome Sporadic Painless, movable mass Wide age distribution Variable size No hydrocele Microscopy: Papillary/tubulopapillary growth Clear cytoplasm Low grade nuclei Nuclei polarized towards the luminal surface

CYSTADENOMA OF THE EPIDIDYMIS CA9 CK7 PAX8

MÜLLERIAN-TYPE EPITHELIAL TUMORS Clinical scenario: Wide age range (adults) No specific medical history Painful testicular swelling Carcinomas may recur and metastasize Pathology: Solid or cystic Wide range of Mülleriantype morphologies Serous features dominate (endometrioid, clear,mucinous, Brenner) Entire histologic spectrum (cystadenomaborderline-carcinoma)

Müllerian rests/metaplasia

ER Müllerian rests/metaplasia within adnexa

Cystadenoma Serous borderline tumor

Papillary serous carcinoma

PARATESTICULAR SEROUS PAPILLARY CARCINOMA Cases 6 Age (yrs) 31 (16-42) Size (cm) 2 (1.5-2.5) Presentation Mass 5 Hydrocele 1 Jones et al. Am J Surg Pathol.1995;19:1359-1365

PARATESTICULAR SEROUS PAPILLARY CARCINOMA: Testicular groove* 4 Paratesticular soft tissue 1 Visceral tunica vaginalis 1 * two cases had extensive visceral tunica vaginalis involvement with invasion of the tunica albuginea Jones et al.am J Surg Pathol.1995;19:1359-1365.

Endometrioid carcinoma

ER WT-1 Positive: PR, CA125, CK7, CD15 Negative: CK20, Calretinin, CEA

LESIONS OF MESOTHELIAL ORIGIN Reactive changes Hyperplasia, cyst Mesothelioma Adenomatoid tumor

When confronted with a hydrocele sac, what should I be thinking about? If the urologist decides to send it to pathology What does the specimen look like? Thin or thick? Smooth or rough surface? What should I submit for morphology? Submit in toto or simply sample? What did the cyst fluid look like? What is the clinical history?

Reactive changes: Thickening Inflammation Mesothelial proliferation parallel to mesothelial surface

Reactive mesothelial hyperplasia Reactive changes: Thickening Inflammation Mesothelial proliferation parallel to mesothelial surface

Reactive mesothelial hyperplasia Respects the underlying muscular coat / no vertical growth

Mesothelioma Haphazard arrangement of cells Nodular of diffuse thickening Vertical growth

Mesothelioma CK 5/6 Calretinin WT-1 Seminiferous tubules

Mesothelioma; morphologic spectrum

What about benign papillary mesothelioma versus WD papillary mesothelioma? Beware of the word benign Minute, focal, cytologically banal, single cell layer, limited to the surface Complexity, solid component, and cytologic atypia warrant a diagnosis of mesothelioma

Papillary mesothelioma

Papillary mesothelioma

MESOTHELIOMA OF TUNICA VAGINALIS Clinicopathologic Features Cases 63 Age (yrs) mean 53.5, range 7-80 Presentation Asbestos exposure 48% Histology Local invasion hydrocele and/or mass 75% epithelial 25% biphasic skin of scrotum/penis, epididymis/testis, spermatic cord Jones et al. Am J Surg Pathol.1995;19:815-825

MESOTHELIOMA OF TUNICA VAGINALIS Sites of Metastasis Site presentation later total (%) Lymph nodes retroperitoneum 9 9 18 (38) inguinal 4 3 7 (15) mediastinal 2 2 (4) Lung 8 8 (17) Peritoneum 3 3 ( 6) Liver 2 2 ( 4) Pelvic soft tissue 3 3 ( 6) Jones et al. Am J Surg Pathol.1995;19:815-825

MESOTHELIOMA OF TUNICA VAGINALIS Outcome of Patients With Follow-up F/U (yrs) Patients DOD AWD NED < 2 19 5 1 13 < 3 15 7 3 5 < 4 4 4 0 0 < 5 7 5 1 1 < 6 3 2 0 1 > 6 4 0 4 0 Total 52 23(44%) 9(17%) 20(39%) Jones et al.am J Surg Pathol.1995;19:815-825

WT1 Calretinin Also: CK5/6 D2-40

ADENOMATOID TUMOR - Well circumscribed, mobile - Not encapsulated Microscopy: - Epithelioid or spindled - Cords, nests, tubules - Microcystic, signet ring - No mitotic activity - May have intervening stroma or adnexal structure - May infarct - atypical myofibroblastic reaction Immunohistochemistry: - Like mesothelioma Differential Diagnosis: Mesothelioma, Adenoca.,YST

ADENOMATOID TUMOR Calretinin WT-1

ADENOMATOID TUMOR

MESENCHYMAL LESIONS OF THE SPERMATIC CORD Fibrous reactive versus neoplastic Lipomatous lipoma liposarcoma dedifferentiated Smooth muscle Squeletal muscle To also consider: Angiolipoma Angiofibroma Angiomyoblastoma Angiomyxoma

NODULAR PERIORCHITIS paratesticular fibrous pseudotumor Non neoplastic Nodular masses single, multiple, confluent Rarely diffuse Plaque-like May be massive and disfiguring Usually unilateral Gross features: Firm to hard, white

NODULAR PERIORCHITIS Microscopic features: Densely hyalinized collagen Clacification Well circumscribed May be somewhat cellular Inflammation Granulation tissue Differential diagnosis: Inflammatory pseudotumor Fibromatosis

Nodular periorchitis Fibrous Pseudotumor

LIPOMA OF THE SPERMATIC CORD

LIPOSARCOMA OF THE CORD - Most common sarcoma at this site - WD liposarcoma / atypical lipomatous tumor Gross appearance: - Variable, based of fatty, fibrous, or dedifferentiated component Microscopy: - Mature appearing adipocytes of varying size - Lipoblasts can be rare - Spindle and florrette-like cells - Fibrous bands are common - Dedifferentiation low grade high grade - Smooth muscle differentiation

Well differentiated Liposarcoma

Dedifferentiated liposarcoma, low grade

Dedifferentiated liposarcoma, high grade

Dedifferentiated Liposarcoma, low grade CDK4 MDM2

Retroperitoneal recurrence Dedifferentiated liposarcoma, now high grade CDK4 MDM2

Adnexal tumors: TESTICULAR APPENDAGES and CORD LESIONS Summary Rare; benign and reactive more common than malignant If epithelioid and malignant, consider a metastasis If primary, location, histology and IHC can help Adenocarcinoma (CEA, CD15, etc) Müllerian (ER, PAX8, WT1, CA125, etc) Mesothelioma (Calretinin, WT1, CK 5/6, Podoplanin) Soft tissue tumors: Beware of the subtle features of WD and low grade dedifferentiated liposarcoma Beware of benign mimics of liposarcoma and embryonal RMS